focus -WSS

focus

author：comprehensive 2025-09-09 03:40:25 - browse：7

Adobe

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would reorient its business around selling its products directly to users over the counter, rather than by prescription.

In connection with the move away from prescription sales, Akili will reduce its workforce by 40%, which the company projects will extend its runway into the second half of 2025. The Boston-based company will continue offering its pediatric treatment, EndeavorRx, by prescription until it can convert it to over-the-counter labeling — it plans to submit data to FDA in 2024.

Akili went public last year and though its prescription sales were slowly increasing, the company’s costs far outstripped its revenues. In its second-quarter results reported in August, Akili said it earned just $114,000 on $15.3 million in expenses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： STAT Wunderkinds: Ruey Hu's digital tools for parsing research

WSS

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

Telehealth options flood the market as retailers push virtual care

Meta's Zuckerberg and Chan on track to put $50 billion into science

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Emergency medicine has repudiated 'excited delirium.' Now what?

An innovative path out of biotech’s “valley of death”

hotspot

focus

explore

Psychedelics group wrestles with new pharma identity

An innovative path out of biotech’s “valley of death”

After affirmative action ruling, medical educators look to 'holistic review'

Genentech weighs delaying cancer therapy after drug pricing law

Anesthesiologist group: stop taking Ozempic before surgery

WHO may add ‘noma' to its list of neglected tropical diseases

Alkermes shareholders re

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Apple is now the first public company to be valued at $3 trillion

Paying for Covid pills will soon shift to insurers

focus

Traditional Chinese medicine benefits explored in new JAMA study

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Cassava reveals details — and problems — with Alzheimer's study

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Timeline: Special counsel's investigation into Trump's handling of classified documents

knowledge

focus

entertainment

leisure time